Measles and rubella vaccination of two million Iranians: complications in vaccinees aged 5-25 years.
In 2003 and 2004, 2,049,170 persons aged 5-25 y were vaccinated against measles and rubella in Tehran. Adverse events were actively monitored. A total of 688 adverse events was reported in 476 vaccine recipients with a female dominance (female to male ratio 2.2). Severe adverse events were noted in 13 cases: seizures within 48 h of vaccination (n = 9), encephalopathy (n = 2), flaccid paralysis (n = 1) and anaphylaxis (n = 1).
Vahdani
Parviz
P
Shahid Beheshti Medical University, Department and Research Centre of Infectious Diseases, Loghman Hakim Hospital, Tehran, Iran. parvizvahdani@yahoo.com
Aminzadeh
Zohreh
Z
Alimardani
Mansour
M
Sharafi
Amran
A
D000293:Adolescent; D000328:Adult; D000707:Anaphylaxis / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007492:Iran; D008297:Male; D008458:Measles Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D009108:Mumps Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D010264:Paraplegia / Q000209:etiology; D012640:Seizures / Q000209:etiology; D017778:Vaccines, Combined / Q000008:administration & dosage / Q000009:adverse effects
D008458:Measles Vaccine; D009108:Mumps Vaccine; D017778:Vaccines, Combined